Birgitta Agerberth, Director of Medical Microbial Pathogenesis of Akthelia Pharmaceuticals was one of two vice-chairs of the conference and also acted as a Discussion Leader during the session on „Understanding biology through the AMPs“. Guðmundur Hrafn Guðmundsson, Chairman of Akthelia‘s board of directors was a discussion leader during the session on „Regulation of AMP expression“ and presented his work in a poster. The participation of Drs Agerberth and Guðmundsson in the conference further establishes their leading role in the field of antibacterial peptides.